Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 24

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 24
---
arrants

In
October 2019, we completed a private placement with certain institutional investors, or the October Private Placement, where we issued
warrants to certain investors, or the October Private Placement Warrants. In May 2020, we completed a private placement with certain institutional
investors, or the May Private Placement, where we issued warrants to certain investors, or the May Private Placement Warrants, the placement
agent, Wainwright, or the Wainwright May Warrants and Armistice Capital, or the May Armistice Warrants. The following is a brief summary
of the October Private Placement Warrants, May Private Placement Warrants, Wainwright May Warrants and the May Armistice Warrants issued
in connection with the October Private Placement and May Private Placement, as applicable, and is subject in all respects to the provisions
contained in the applicable warrants, which are filed as exhibits to this Registration Statement on Form F-1. On December 13, 2022, the
exercise price of the October Private Placement Warrants granted to Armistice Capital and the May Private Placement Warrants was increased
to $8,000.00. Unless otherwise stated, references to warrants in this section include the October Private Placement Warrants, May Private
Placement Warrants and Wainwright May Warrants.

Exercisability.
The October Private Placement Warrants became exercisable on December 23, 2019. The May Private Placement Warrants, May Armistice Warrants
and Wainwright May Warrants became exercisable upon issuance. The October Private Placement Warrants, May Private Placement Warrants and
May Armistice Warrants will expire five and one-half years from the initial exercise date, and the Wainwright May Warrants will expire
on May 18, 2025. The holder shall deliver the aggregate exercise price for the American depositary shares (each representing 10,000 Ordinary
Shares) or the Depositary Shares specified in the exercise notice within two trading days following the date of exercise (subject to the
‘cashless exercise’ arrangements described below).

Cashless Exercise. With respect to the October Private Placement Warrants, if, more than six months after the date of issuance of such warrants,
there is no effective registration statement registering, or no current prospectus available for, the resale of the Depositary Shares
underlying such warrants, the holder may exercise the warrant, in whole or in part, on a cashless basis.